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Aborigines in remote areas of Australia have much higher
rates of renal disease, as well as hypertension and
cardiovascular disease, than non-Aboriginal Australians. We
compared kidney findings in Aboriginal and non-Aboriginal
people in one remote region. Glomerular number and mean
glomerular volume were estimated with the disector/
fractionator combination in the right kidney of 19 Aborigines
and 24 non-Aboriginal people undergoing forensic autopsy
for sudden or unexpected death in the Top End of the
Northern Territory. Aborigines had 30% fewer glomeruli than
non-Aborigines – 202 000 fewer glomeruli per kidney, or an
estimated 404 000 fewer per person (P¼ 0.036). Their mean
glomerular volume was 27% larger (P¼ 0.016). Glomerular
number was significantly correlated with adult height,
inferring a relationship with birthweight, which, on average,
is much lower in Aboriginal than non-Aboriginal people.
Aboriginal people with a history of hypertension had 30%
fewer glomeruli than those without – 250 000 fewer per
kidney (P¼ 0.03), or 500 000 fewer per person, and their
mean glomerular volume was about 25% larger. The lower
nephron number in Aboriginal people is compatible with
their susceptibility to renal failure. The additional nephron
deficit associated with hypertension is compatible with other
reports. Lower nephron numbers are probably due in part to
reduced nephron endowment, which is related to a
suboptimal intrauterine environment. Compensatory
glomerular hypertrophy in people with fewer nephrons,
while minimizing loss of total filtering surface area, might be
exacerbating nephron loss. Optimization of fetal growth
should ultimately reduce the florid epidemic of renal disease,
hypertension, and cardiovascular disease.
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An epidemic of renal failure has appeared over the last 20
years among Aborigines living in remote areas of Australia.
The average current incidence of treated end-stage renal
disease exceeds 1500 per million and the age-adjusted rate is
more than 20 times than that of non-Aboriginal Australians,
whereas the incidence approaches 3000 pm in some commu-
nities.1,2 Pathologic albuminuria or proteinuria, which marks
the underlying renal disease, is pervasive in all remote
communities that have been studied, with rates and levels
increasing with age.3–9 An epidemic of cardiovascular disease,
type II diabetes, and hypertension has developed in parallel
and cardiovascular disease is now the leading cause of death,
with rates three to six times those of non-Aboriginal
people.10,11 Renal disease is intimately related to these
conditions, and all can be understood in the context of the
rapid epidemiologic transition these people have experienced
in the last four or five decades, and their current profound
socioeconomic disadvantage.3,4,12–15
Our studies show that renal disease in the Aboriginal
community setting is multideterminant, with a multitude of
risk factors operating across the life course to amplify
progressively renal injury and the loss of renal function that
accompanies increasing age.4 Others have proposed a similar
concept.16 We have demonstrated that low birthweight is one
important risk factor operating in the Aboriginal environ-
ment, and proposed it might act through reduced nephron
endowment.17,18
Some years ago, Brenner et al.19 proposed that reduced
nephron endowment might be a fundamental cause of
essential hypertension, and might also predispose to renal
insufficiency.20 Furthermore, they proposed that both these
processes might be exacerbated by accelerated loss of
remaining nephrons owing to hyperperfusion injury of
glomeruli that had undergone compensatory hypertrophy.21
In a study of 78 coronial (forensic) series of autopsies
from the USA and Australia (now updated to 220), we
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described a 10-fold range in nephron numbers in kidneys of
‘normal’ people, and proposed that those at the lower end of
the spectrum may be predisposed to kidney failure on the
basis of reduced nephron endowment.22 We described a
progressive loss of glomeruli over the course of adult life, and
a strong inverse correlation between average glomerular
volume and nephron number, which probably represents
compensatory hypertrophy in remaining nephrons when
numbers are limiting. Furthermore, we showed in the US
subjects that birthweight over a continuum was a powerful
determinant of nephron number and, inversely, of glomer-
ular volume.23
Recently, Keller et al.24 demonstrated a dramatically lower
number of nephrons in people with essential hypertension,
with enlargement of glomeruli that remained. These
phenomena, although somewhat less pronounced, were then
confirmed among Whites in the US autopsy series.25,26 In all
these instances, the presumed compensatory hypertrophy in
residual glomeruli tended to ‘restore’ total glomerular
volume towards more ‘normal’ values than the lower
nephron number would predict.
In this report, we analyze findings in Aboriginal people
from the US/Australian study and speculate how the
observations might relate to disease susceptibility.
RESULTS
Most of the observations described for the entire series22
applied for the Australian series separately. Nephron number
tended to be lower in females than in males, by 11% in the
combined ethnic groups, and by 5% in Aboriginal people
specifically, but the differences were not significant (P¼ 0.40
and 0.63, respectively). Mean glomerular volume and kidney
mass did not differ significantly by sex. Nonetheless, all
comparative analyses were adjusted for sex as well as age.
Figure 1a shows the loss of glomeruli during adult life,
Figure 1b shows the inverse correlations between mean
glomerular volume and glomerular number, and Figure 1c
shows the strong influence of body size on kidney weight.
There were only six available birthweights in the
Australian series, which was insufficient for meaningful
analysis. The five available birthweights for Aboriginal people
were 1.81, 2.4, 2.665, 2.88, and 4.01 kg, with a mean of 2.75
(s.d. 0.8) kg. This is 600 g less than the current Australian
average birthweight, and is precisely the average of young
adults in the community in which birthweight effects have
been studied most thoroughly, where 35% of people aged
20–39 years had weighed o2.5 kg at birth.4,17,18,27–29 How-
ever, glomerular number was strongly related to height in
adults (Figure 1d), which birthweight predicts.30 In this
analysis, height contributed two-thirds of the explained
variance in glomerular number.
Table 1 compares characteristics of the participants in the
Australian series by ethnic group. There was a greater
proportion of females in the Aboriginal group, reflecting
higher rates of unexplained or sudden death in Aboriginal
than non-Aboriginal females. Aborigines were also younger
at the time of death on average, and were lighter and shorter
than non-Aboriginal people. Table 2 shows that they had, on
average, 202 000 fewer glomeruli in a single kidney than non-
Aboriginal people (or about 30% fewer), and their mean
glomerular tuft volume was significantly larger (by about
27%). Their kidney weight was significantly lower. Their
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Figure 1 | Autopsy findings, right kidney, in adults (18þ year) in the Australian series, adjusted for age, sex, and race. (0) Aboriginal;
(x) non-Aboriginal.
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estimated total glomerular mass, which is not an independent
measurement, but the product of glomerular number and
mean glomerular volume, did not differ, implying that
glomerular hypertrophy adequately compensated the reduc-
tion in filtering surface threatened by reduced glomerular
number. There was no difference in the proportions of
glomeruli that were sclerosed, nor in the amount of cortical
fibrosis (not shown), which paralleled glomerulosclerosis
very closely.
Figure 2 demonstrates the different distribution of kidney
characteristics in the Australian series. There was a significant
leftwards shift of glomerular number among Aborigines, a
rightward shift in mean glomerular volume, and a leftward
shift in kidney mass. However, the distributions of the
percentage of sclerosed glomeruli were similar.
Fourteen Aboriginal adults had a fairly reliable clinical
history, allowing allocation of a diagnosis of hypertension in
five. Those with a history of hypertension had significantly
fewer glomeruli than those without (Figure 3a), whereas their
mean glomerular volume tended to be larger (Figure 3b). As
a result, estimated total glomerular volume did not differ
significantly, at 5.9 cm3 (95% confidence interval 4.5–7.3) for
those without hypertension and 5.7 (3.8–7.6) for those with
hypertension, P¼ 0.87.
There were no differences in glomerular number accord-
ing to the presence of ischemic heart disease in Aborigines.
This applied whether the death was finally attributed to
ischemic heart disease and coronary atherosclerosis, and
whether people with an ‘incidental’ finding of moderate or
severe coronary artery disease at autopsy were also included.
DISCUSSION
Aboriginal people in the Northern Territory of Australia who
underwent forensic autopsy for sudden or unexpected death,
without an advance suspicion of renal disease, had sig-
nificantly fewer nephrons than non-Aboriginal people
undergoing autopsy at the same center. They also had a
larger mean glomerular volume. In addition, Aboriginal
adults with a history of hypertension had significantly fewer
nephrons than Aborigines without a history of hypertension,
and the glomeruli of those nephrons were, on average, larger.
Rates of renal failure in Aboriginal people from this region
are among the highest in Australia,1 and adults in every
community tested have very high rates of albuminuria.8,9 It is
probable that reduced nephron number is contributing to the
accentuated susceptibility to renal disease and to its
progression.20 The association of lower nephron numbers
in Aboriginal people with hypertension is a direct confirma-
tion of a relationship long suggested:19 it supports the
observations of Keller et al.24 in Europe, and more recently of
Hughson et al. in the US autopsy series,25,26 and is
compatible with the high rates of hypertension in the
Aboriginal population.8,9
The larger mean glomerular volume in Aboriginal people
in general, and in those with hypertension in particular, is
consistent with compensatory hypertrophy of remaining
Table 1 | Characteristics of adult participants, Aboriginal vs
Non-Aboriginal people
Aboriginal, n=17 Non-aboriginal, n=24 P-value
Male:female 11:6 21:3
Age (year) 38.5 (12.4) 46.8 (19.0) P=0.124
Height (cm)a 168.1 (166–171) 172.7 (170–174) P=0.0109
Weight (kg)a 58.9 (51–67) 79.0 (73–85) P=0.0006
BMI (kg/m2)a 20.8 (18.1–23.5) 26.6 (24.4–28.9) P=0.0034
BSA (m2)a 1.65 (1.54–1.76) 1.95 (1.86–2.04) P=0.0003
BMI, body mass index; BSA, body surface area.
aAdjusted for age and sex.
Table 2 | Characteristics, right kidney, Aboriginal vs non-Aboriginal people
Aboriginal Non-aboriginal P-value
Kidney weight (g)
Range 97–246 95–326 P=0.019*
Mean (95% CI)* 160.4 (131–189) 209.1 (185–223)
Nglom
Range 364 262–1 129 233 380 517–1 493 665 P=0.036
Mean (95% CI)* 683 174 (552 954–813 393) 885 318 (770 885–999 751)
Vglom (mm3 106)
Range 4.7–11.1 3.3–13.4 P=0.022
Mean (95% CI)* 8.4 (7.3–9.5) 6.6 (5.7–7.5)
Vglomtot (cm3)
Range 4.7–10.4 2.7–11 P=0.79
Mean (95% CI)* 5.7 (4.7–6.7) 5.5 (4.7–6.4)
Glomerulosclerosis (%)
Range 0–8.7 0–12.2 P=0.82**
Median, IQR 1.68 (0.6–5.2) 1.52 (0.8–4.7)
CI, confidence interval; IQR, interquartile range; Nglom, glomerular number; Vglom, mean glomerular volume; Vglomtot, total glomerular volume.
*Average values adjusted for age and sex.
**By rank-sum test.
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nephrons in situations of nephron deficit. This process seems
to reasonably compensate total glomerular mass, at least in
most people and for some time. It is not known whether
hyperfusion injury operates on a continuum or becomes
manifest at some critical glomerular size. However, the range
of glomerular volumes disguised by the ‘mean’ value for each
kidney is large,31 and in people with large mean values the
maximum might be very large indeed.
The similar proportions of sclerosed glomeruli in the two
groups argue against an excessive loss of nephrons as the
major cause of the reduced glomerular number in the
Aboriginal group, supporting the hypothesis that the lower
glomerular numbers are largely related to reduced nephron
endowment. While acknowledging possible genetic and long-
term adaptive influences on kidney development, the major
cause is probably limitation of kidney development through a
suboptimal intrauterine environment.32–38 This is most
commonly associated with generalized intrauterine growth
restriction. Major agents or associations include small
maternal size, particularly with low weight for height, which
is the major cause of low birthweight internationally,39,40
global malnutrition or micronutrient deficiency (with
Vitamin A deficiency a likely candidate), and smoking. The
impact of maternal smoking is huge, with estimates that fetal
weight is reduced by 10–15 g/cigarette smoked per day.39–42
Fetal growth is also restricted by hypoxia, infections, toxins,
certain drugs, metabolic perturbations, including hyper-
glycemia, and probably psychosocial as well as physical
stress. Finally, it is now known that nephrogenesis does not
proceed optimally after premature birth, even in babies
whose intrauterine growth was satisfactory until close to
delivery.43,44
All of these factors operate at high density in the remote
Aboriginal community setting. Frank hunger is common and
the global diet is of poor quality, with fresh fruit and
vegetables particularly lacking. Infections are many and social
and psychological stresses often severe. In a study of
Aboriginal children born in remote communities across the
NT in the late 1980s and early 1990s,37,38 27.5% were small
for gestational age and 10.3% were premature births; 31% of
the 473 mothers were ‘underweight’ by Australian standards
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Figure 3 | Kidney characteristics in adults Aborigines with and
without hypertension, adjusted for age and sex.
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Figure 2 | Distribution of findings in the right kidney by category, Aboriginal vs non-Aboriginal adults.
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(body mass indexo20 kg/m2); and 16% met the WHO
standards for malnutrition for women (body mass index-
o18.5 kg/m2); 18.5% were under 18 years of age, whereas
56% smoked and 15% drank alcohol while pregnant.45–47
Smoking was associated with intrauterine growth restriction,
whereas low maternal body mass index, as well as drinking
during pregnancy, were associated with relatively smaller
kidneys and high rates of pathologic albuminuria in their
offspring at ages 10–14 years.48 The picture was scarcely better
between 2000 and 2002, when Northern Territory-wide
government data showed that 46% of all Aboriginal mothers
smoked and 11.4% continued to drink alcohol while
pregnant.
The autopsy results are compatible with epidemiologic
and clinical data. In the community setting, young adult
people with lower birthweights have higher rates of
pathologic albuminuria and higher blood pressures than
those with normal birthweights.17,18,27 Children of lower
birthweight have smaller kidneys than those of higher
birthweights,28 and adults with smaller kidneys have higher
blood pressures and rates of albuminuria than those with
larger kidneys.29 The glomerular enlargement associated with
reduced nephron number is compatible with the marked
glomerulomegaly seen in most kidney biopsies from
Aboriginal people with clinical renal disease from this region,
and with the progressive glomerular sclerosis which accom-
panies it.49,50
Ironically, improvements in health care have probably
contributed to the current chronic disease epidemic. Owing
to better care of sick infants, infant mortality in Aborigines in
the Northern Territory fell from about 160/1000 births in the
early 1960s to about 28/1000 now, with most of the prior
excess deaths and subsequent retrieval among infants with
intrauterine growth restriction. Thus, large cohorts of low
birthweight babies have survived to adolescence and adult
life, potentially, at high risk for chronic diseases.17,18,28,29,51
The findings and the postulated pathways help explain the
current epidemic of kidney and related chronic diseases in
Aboriginal people, and point to obvious remedies. Body
habitus cannot be substantially changed in an existing
generation of adolescents and young women, and excessive
weight gain itself exacerbates their own risk of chronic
disease.4,8,9 Optimal birthweights for Aboriginal children are
not known. However, for those still unborn, a favorable
intrauterine environment that promotes optimal organogen-
esis is obviously desirable. For people already alive, the
challenge is to optimize survival of their existing nephrons,
by avoiding postnatal renal insults, which abound in these
environments (infections, poststreptococcal glomerulone-
phritis, malnutrition, toxins, drugs, smoking, alcohol abuse,
acute renal failure), and by minimizing metabolic and
vascular stressors. As for the broader population, one
fundamental challenge is avoiding excessive weight gain.
Additional benefits might accrue from a well-rounded diet-
rich in antioxidants.52 For very high-risk communities, a trial
of medical prophylaxis is planned. Finally, vigorous and
appropriate renal and vascular sparing therapy for those who
need it promises substantial delay or avoidance of morbid-
ities, renal failure and premature death.53,54
MATERIALS AND METHODS
Participants were people subjected to autopsy for sudden or
unexpected death at the Royal Darwin Hospital in the Northern
Territory of Australia and at the University of Mississippi Medical
Centre in Jackson, MS, USA. The handling and testing of kidneys
has been described in detail previously.55,22 Briefly, both kidneys
were weighed, the right kidney was perfusion-fixed with formalin,
and was systematically sampled for stereologic study. Mean
glomerular volume and total glomerular number were estimated
by the disector/fractionator combination. Kidney sections were
examined by light microscopy (MDH), and the proportions of
obsolete glomeruli and cortical atrophy were assessed in sections
stained with Periodic Acid Schiff, Alcian Blue Hematoxylin, and
Masson Trichrome.
For the Australian participants, autopsy findings were recorded
and the causes of death were ascertained, initially through the local
Coroner’s records, and more recently through the National Coronial
Information System. Enquiries about the previous health of the
participants were made through the next-of-kin who gave consent,
through medical records at the Royal Darwin Hospital, where
available, and, for Aboriginal people, enquiries of the community
clinics. A health history was more adequate in Aboriginal than in
non-Aboriginal people; the latter had usually not been long-term
residents in the area, they lacked local records, and their next-of-kin
often knew little of their clinical histories. Aboriginal people were
allocated a history of hypertension if their local clinic confirmed that
such a diagnosis had been made in the past, the standard definition
being a blood pressure X140/90 mm Hg on at least two occasions.
Attempts to gather birthweights were largely unsuccessful, in part,
because these were not systematically recorded for Aboriginal people
until the early 1970s.
The Australian series consisted of 19 Aborigines (18 adults, of
18þ year) and 24 non-Aboriginal people (all 18þ year). The
Aboriginal people all came from remote areas. Clinical histories and
coronial autopsy findings were not available for two. Of the 17
Aboriginal people (16 adults) with autopsy findings accessed, 12
died of natural causes (including a baby with sudden infant death
syndrome) and five died deaths of misadventure (suicide, accidents,
poisoning). Among the 11 deaths of adults attributed to natural
causes, eight were associated with atherosclerotic vascular disease:
six were attributed to ischemic heart disease/coronary atherosclero-
sis, alone in four, and in conjunction with pneumonia and drug
toxicity (one each); an additional person died of a ruptured aortic
dissection, and another died of pneumonia, with an old myocardial
infarction. Among the five adults dying deaths of misadventure, one
had mild and another had moderate coronary artery atherosclerosis.
The general features of the Australian data were assessed, then
the Aboriginal and non-Aboriginal data were compared. This
optimizes regional matching, involves a single harvesting center, and
allows adjustments for differences in age, gender, and body size
across ethnic groups.
Analyses were carried out with STATA statistical package, Version 8
(College Station, Texas, USA). Kidney data were analyzed as continuous
and as categorical variables. Linear and polynomial multivariate
regressions were used to assess the magnitude and strength of associ
ations of kidney variables with one another and with other factors.
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